BioNTech BNTX
$80.96 −$0.42 (-0.52%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $81.00 +0.05%
Open$80.82
Prev close$81.38
Day range$80.27 – $82.87
Volume1.71M
Market cap$20.07B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026 · reported in EUR
Revenue€1.29B-15.1% YoY
Operating profit€138.10M-78.9% YoY
Net profit€184.50M+742.9% YoY
Diluted EPS€0.73+708.3% YoY
Free cash flow-€178.30M-124.0% YoY
Operating cash flow-€129.80M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin75.0%
Operating margin-72.7%
Net margin-60.9%
Return on equity-8.1%
Return on assets-7.1%
Return on invested capital-8.0%
Current ratio8.55
Liabilities / assets12.2%
Cash & investments€14.66B
Total debt€312.80M
Net cash (debt)€14.34B
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
Income statement
| Line item | 2026 Q3 (EUR) |
2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
|---|---|---|---|---|---|
| Total Revenue as Reported | €1.29B | €105.60M | €118.10M | €2.87B | €907.40M |
| Total Operating Revenue | €1.29B | €105.60M | €118.10M | €2.87B | €907.40M |
| Cost of Revenue | €103.30M | €97.00M | €71.40M | €641.80M | €333.30M |
| Gross Profit | €1.19B | €8.60M | €46.70M | €2.23B | €574.10M |
| Operating Expense | €1.05B | €947.30M | €724.20M | €2.87B | €854.60M |
| Selling and Admin Expenses | €202.00M | €197.80M | €150.80M | €698.20M | €291.70M |
| -Selling & Marketing Expense | €43.30M | €40.10M | €27.90M | €110.00M | €49.30M |
| -General & Admin Expense | €158.70M | €157.70M | €122.90M | €588.20M | €242.40M |
| Research & Development | €748.10M | €551.00M | €557.00M | €2.10B | €505.40M |
| Other Operating Expenses | €97.70M | €198.50M | €16.40M | €65.70M | €57.50M |
| Operating Profit | €138.10M | -€938.70M | -€677.50M | -€640.70M | -€280.50M |
| Net Non-Operating Interest Income (Expense) | €67.80M | €62.70M | €109.40M | -€12.60M | -€5.10M |
| Non-Operating Interest Income | €69.80M | €66.40M | €120.60M | – | – |
| Non-Operating Interest Expense | €3.50M | €3.50M | €11.20M | €14.20M | – |
| Total Other Finance Costs | -€1.50M | €200,000.00 | €700,000.00 | -€1.60M | -€9.30M |
| Other Income (Expense) | €16.10M | €17.30M | €46.10M | -€397.50M | €58.20M |
| Gain on Sale of Security | €29.30M | €24.40M | €46.40M | €383.40M | €110.30M |
| Special Income (Charges) | -€13.20M | -€7.10M | -€300,000.00 | -€780.90M | -€52.10M |
| -Less:Restructuring and Mergern & Acquisition | €0.00 | €0.00 | €0.00 | -€15.00M | €0.00 |
| -Less:Other Special Charges | €13.50M | €7.10M | – | €789.50M | €45.70M |
| -Less:Write Off | -€300,000.00 | €0.00 | €300,000.00 | €6.40M | – |
| Pretax Profit | €222.00M | -€858.70M | -€568.10M | -€1.05B | -€227.40M |
| Tax | €37.50M | -€37.90M | -€36.20M | €85.30M | €77.60M |
| Net Profit | €184.50M | -€820.80M | -€531.90M | -€1.14B | -€305.00M |
| Profit from Continuing Operations | €184.50M | -€820.80M | -€531.90M | -€1.14B | -€305.00M |
| Net Income to Parent Company | €184.50M | -€820.80M | -€531.90M | -€1.14B | -€305.00M |
| Net Income to Common Stockholders | €184.50M | -€820.80M | -€531.90M | -€1.14B | -€305.00M |
| Basic EPS | €0.74 | -€3.24 | -€2.10 | -€4.70 | -€1.25 |
| Diluted EPS | €0.73 | -€3.24 | -€2.10 | -€4.70 | -€1.25 |
Balance sheet
| Line item | 2026 Q3 (EUR) |
2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
|---|---|---|---|---|---|
| Total Assets | €20.17B | €20.34B | €21.07B | €21.99B | €21.99B |
| Total Current Assets | €15.67B | €15.30B | €15.53B | €16.15B | €16.15B |
| Cash and Cash Equivalents & Short-Term Investments | €14.66B | €14.78B | €14.64B | €14.88B | €14.88B |
| -Cash and Cash Equivalents | €10.20B | €9.74B | €9.94B | €7.68B | €7.68B |
| -Short Term Investments | €4.46B | €5.04B | €4.70B | €7.20B | €7.20B |
| Receivables | €796.00M | €245.20M | €612.20M | €984.90M | €984.90M |
| -Accounts Receivable | €666.30M | €163.90M | €539.20M | €924.20M | €924.20M |
| -Taxes Receivable | €124.30M | €70.90M | €64.10M | €52.60M | €52.60M |
| -Other Receivables | €5.40M | €10.40M | €8.90M | €8.10M | €8.10M |
| Inventory | €64.90M | €100.60M | €103.80M | €110.70M | €110.70M |
| Other Current Assets | €145.20M | €172.70M | €176.60M | €173.80M | €173.80M |
| Total Non-Current Assets | €4.50B | €5.05B | €5.54B | €5.84B | €5.84B |
| Net PPE | €1.16B | €1.22B | €1.32B | €1.29B | €1.29B |
| -Gross PPE | €1.16B | €1.22B | €1.32B | €1.77B | €1.77B |
| Investments and Advances | €1.73B | €2.01B | €2.28B | €2.55B | €2.55B |
| -Available for Sale Securities | €1.67B | €2.01B | €2.28B | €2.55B | €2.55B |
| Financial Assets | €0.00 | – | – | – | – |
| Goodwill and Other Intangible Assets | €1.58B | €1.79B | €1.92B | €1.97B | €1.97B |
| -Goodwill | €376.00M | €373.30M | €370.50M | €367.90M | €367.90M |
| -Other Intangible Assets | €1.20B | €1.42B | €1.55B | €1.61B | €1.61B |
| Non-Current Deferred Assets | €20.00M | €15.70M | €14.70M | €13.50M | €13.50M |
| Other Non-Current Assets | €15.00M | €10.30M | €12.20M | €7.30M | €7.30M |
| Total Liabilities | €2.46B | €2.59B | €2.38B | €2.76B | €2.76B |
| Total Current Liabilities | €1.83B | €1.95B | €1.77B | €2.14B | €2.14B |
| Payables | €536.30M | €667.90M | €506.90M | €600.50M | €600.50M |
| -Accounts Payable | €523.10M | €646.70M | €468.80M | €534.90M | €534.90M |
| -Total Tax Payable | €13.20M | €21.20M | €38.10M | €65.60M | €65.60M |
| Short-Term Debt and Capital Lease Obligation | €104.40M | €57.20M | €56.70M | €52.20M | €52.20M |
| -Current Debt | €57.40M | €57.20M | €56.70M | €52.20M | €52.20M |
| -Current Capital Lease Obligation | €47.00M | – | €45.90M | – | – |
| Current Provisions | €244.20M | €234.90M | €167.00M | €145.30M | €145.30M |
| Current Deferred Liabilities | €623.60M | €742.50M | €758.50M | €754.90M | €754.90M |
| Other Current Liabilities | €324.30M | €246.70M | €275.90M | €589.40M | €589.40M |
| Total Non-Current Liabilities | €629.30M | €635.90M | €611.30M | €622.10M | €622.10M |
| Long Term Debt and Capital Lease Obligation | €255.40M | €258.90M | €246.10M | €215.20M | €215.20M |
| -Long Term Debt | €110.80M | €258.90M | €246.10M | €215.20M | €215.20M |
| -Long Term Capital Lease Obligation | €144.60M | – | €179.50M | – | – |
| Derivative Product Liabilities | €0.00 | – | – | – | – |
| Non-Current Liabilities | €64.60M | €58.60M | €23.80M | €35.50M | €35.50M |
| Non-Current Deferred Liabilities | €83.30M | €120.90M | €140.60M | €172.30M | €172.30M |
| Other Non-Current Liabilities | €226.00M | €197.50M | €200.80M | €199.10M | €199.10M |
| Total Equity | €17.71B | €17.76B | €18.70B | €19.22B | €19.22B |
| Stockholders' Equity | €17.71B | €17.76B | €18.70B | €19.22B | €19.22B |
| Capital Stock | €259.00M | €259.00M | €259.00M | €259.00M | €259.00M |
| -Common Stock | €259.00M | €259.00M | €259.00M | €259.00M | €259.00M |
| Additional Paid-In Capital | €2.08B | €2.34B | €2.47B | €2.47B | €2.47B |
| Retained Earnings | €16.79B | €16.61B | €17.43B | €17.96B | €17.96B |
| Less: Treasury Stock | -€11.10M | -€7.80M | -€6.10M | -€7.70M | -€7.70M |
| Gains/Losses Not Affecting Retained Earnings | -€1.41B | -€1.44B | -€1.45B | -€1.46B | -€1.46B |
| -Accumulated Depreciation | – | – | – | -€475.50M | -€475.50M |
| Non Current Accounts Receivables | – | – | – | €2.00M | €2.00M |
Cash flow
| Line item | 2026 Q3 (EUR) |
2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
|---|---|---|---|---|---|
| Operating Cash Flow | -€129.80M | €10.50M | -€421.00M | €456.00M | €309.50M |
| Net cash flow from continuing operations | -€129.80M | €10.50M | -€421.00M | €456.00M | €309.50M |
| Net Income from Continuing Operations | €184.50M | -€858.70M | -€568.10M | -€1.05B | -€219.70M |
| Gain/Loss from Continuing Operations | -€3.30M | €16.40M | €300,000.00 | -€19.50M | -€54.20M |
| Depreciation & Depletion & Amortization | €332.30M | €266.10M | €121.30M | €382.80M | €164.80M |
| Deferred Tax | €37.50M | – | – | – | – |
| Other Non-Cash Items | -€89.10M | -€80.50M | -€105.20M | €169.70M | €517.20M |
| Change in Working Capital | -€653.20M | €593.90M | €66.20M | €537.80M | -€214.50M |
| -Change in Receivables | -€489.10M | €366.00M | €431.10M | €1.08B | €78.20M |
| -Change in Inventory | €33.50M | €3.20M | €7.00M | €177.90M | €116.20M |
| -Change in Payables and Accrued Expense | -€197.60M | €224.70M | -€371.90M | -€723.80M | -€408.90M |
| Net cash flow from investing | €807.70M | -€100.10M | €2.65B | -€2.47B | -€2.73B |
| Net Cash Flow from Continuing Investing Activities | €807.70M | -€100.10M | €2.65B | -€2.47B | -€2.73B |
| Net PPE Purchase and Sale | -€32.10M | -€51.20M | -€55.20M | -€170.60M | -€62.60M |
| Net Intangibles Purchase and Sale | -€14.90M | -€800,000.00 | -€22.10M | -€573.90M | €1.10M |
| Net Business Purchase and Sale | -€31.80M | €0.00 | €0.00 | €186.30M | €264.80M |
| Net Investment Purchase and Sale | €886.50M | -€48.10M | €2.73B | -€1.91B | -€2.93B |
| Financing Cash Flow | -€232.60M | -€108.50M | €26.40M | -€52.90M | -€14.30M |
| Net Cash Flow from Continuing Financing Activities | -€232.60M | -€108.50M | €26.40M | -€52.90M | -€14.30M |
| Net Issuance Payments Of Debt | €41.70M | €20.70M | €26.40M | -€50.90M | -€12.30M |
| Net Common Stock Issuance | -€274.30M | -€129.20M | – | €0.00 | €0.00 |
| Ending Cash Balance | €10.20B | €9.74B | €9.94B | €7.68B | €7.68B |
| Net Change in Cash | €445.30M | -€198.10M | €2.26B | -€2.07B | -€2.43B |
| Beginning Cash Balance | €9.74B | €9.94B | €7.68B | €9.76B | €10.09B |
| Effect of Exchange Rate Changes | €2.00M | -€3.30M | -€3.40M | -€27.00M | €1.40M |
| Free Cash Flow | -€178.30M | -€44.90M | -€499.90M | -€293.00M | €247.40M |
| Net Other Financing Charges | – | – | – | -€2.00M | – |
No comments yet — be the first to weigh in on BNTX.
Sign in to join the discussion.